EGFR was found to be overexpressed in majority (66–84%) of dysplastic and HNSCC samples (Figure 2a) while, a low frequency of amplification (26.4%) was observed in these samples (Figure 2b). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.